Ting‐Yu Kao

899 total citations
24 papers, 770 citations indexed

About

Ting‐Yu Kao is a scholar working on Oncology, Physiology and Molecular Biology. According to data from OpenAlex, Ting‐Yu Kao has authored 24 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Ting‐Yu Kao's work include Thermoregulation and physiological responses (7 papers), Thermal Regulation in Medicine (4 papers) and Adipose Tissue and Metabolism (4 papers). Ting‐Yu Kao is often cited by papers focused on Thermoregulation and physiological responses (7 papers), Thermal Regulation in Medicine (4 papers) and Adipose Tissue and Metabolism (4 papers). Ting‐Yu Kao collaborates with scholars based in Taiwan and United States. Ting‐Yu Kao's co-authors include Mao‐Tsun Lin, M. T. Lin, Chung‐Ching Chio, Ying Jin, Alan Yueh‐Luen Lee, Chi‐Chen Fan, Chih‐Ping Hsu, C.F. Chen, Shih Sheng Jiang and Tao‐Yeuan Wang and has published in prestigious journals such as Stroke, Journal of Applied Physiology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Ting‐Yu Kao

24 papers receiving 759 citations

Peers

Ting‐Yu Kao

PHYSI

CCICM

ONCOL

HTM

Yongan Wang China

Xiaoling Zhao China

Jorge Barroso-Aranda United States

Shohei Shinozaki Japan

Ikuhiro Hirata Japan

Aizhong Wang China

Adam P. Lightfoot United Kingdom

Alessio Ardizzone Italy

Xinwei Huang China

Guihua Zhou China

Yongan Wang China

Ting‐Yu Kao

228 ×0.8

36 ×0.1

PHYSI

36 ×0.3

CCICM

51 ×0.4

ONCOL

40 ×0.4

HTM

Citations per year, relative to Ting‐Yu Kao Ting‐Yu Kao (= 1×) peers Yongan Wang

Countries citing papers authored by Ting‐Yu Kao

Since Specialization

Citations

This map shows the geographic impact of Ting‐Yu Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Yu Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Yu Kao more than expected).

Fields of papers citing papers by Ting‐Yu Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Yu Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Yu Kao. The network helps show where Ting‐Yu Kao may publish in the future.

Co-authorship network of co-authors of Ting‐Yu Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Yu Kao. A scholar is included among the top collaborators of Ting‐Yu Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Yu Kao. Ting‐Yu Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Wei-Lun, et al.. (2025). CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells. Cancer & Metabolism. 13(1). 6–6. 2 indexed citations

Chung, Yuan‐Chiang, Chiu-Chen Huang, Ming‐Tsung Lai, et al.. (2024). Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Interleukin-6 Receptor. Pharmaceuticals. 17(1). 127–127. 4 indexed citations

Kuo, Cheng‐Liang, Han-Yu Chou, Hui‐Wen Lien, et al.. (2022). A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment. Cancer Immunology Immunotherapy. 72(2). 351–369. 12 indexed citations

Kao, Ting‐Yu, et al.. (2021). Characterization of a fluorescent glucose derivative 1-NBDG and its application in the identification of natural SGLT1/2 inhibitors. Journal of Food and Drug Analysis. 29(3). 521–532. 5 indexed citations

Chung, Yuan‐Chiang, et al.. (2021). Antibody to Interleukin-6 Receptor InhibitsIn VivoGrowth of Human Colorectal Carcinoma Cell Xenografts. Anticancer Research. 41(10). 4907–4916. 4 indexed citations

Kao, Ting‐Yu, et al.. (2020). Innovative Mind–Body Intervention Day Easy Exercise Increases Peripheral Blood CD34⁺ Cells in Adults. Cell Transplantation. 29. 2790874883–2790874883. 1 indexed citations

Kao, Ting‐Yu, Cheng‐Liang Kuo, Chi‐Chen Fan, et al.. (2018). Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity. Cell Death and Disease. 9(6). 697–697. 42 indexed citations

Chung, Yuan‐Chiang, Chin‐Hui Chen, Yu-Ting Tsai, et al.. (2017). Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cells. BMC Complementary and Alternative Medicine. 17(1). 16–16. 20 indexed citations

Lee, Alan Yueh‐Luen, et al.. (2015). Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway. Integrative Cancer Therapies. 14(5). 484–490. 78 indexed citations

10.

Yang, Cheng‐Yao, et al.. (2014). PREVENTIVE EFFECTS OF BORAGE OIL AND LING-ZHI-8 PROTEIN ON CARBON TETRACHLORIDE-INDUCED ACUTE HEPATIC TOXICITY IN RATS.. 91–100. 6 indexed citations

11.

Fan, Chi‐Chen, et al.. (2013). Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 139(10). 1735–1744. 79 indexed citations

12.

Kao, Ting‐Yu, et al.. (2012). Effects of ellagic acid on chemosensitivity to 5-fluorouracil in colorectal carcinoma cells.. PubMed. 32(10). 4413–8. 29 indexed citations

13.

Hsu, Chih‐Ping, Yung‐Liang Chen, Chiu-Chen Huang, et al.. (2010). Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. European Journal of Clinical Investigation. 41(3). 277–284. 38 indexed citations

14.

Kao, Ting‐Yu, et al.. (2010). Clinical significance of tumor suppressor PTEN in colorectal carcinoma. European Journal of Surgical Oncology. 37(2). 140–147. 59 indexed citations

15.

Kao, Ting‐Yu, et al.. (1996). Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist. Neuroscience Research. 24(2). 159–163. 22 indexed citations

16.

Kao, Ting‐Yu, et al.. (1996). Brain serotonin depletion attenuates heatstroke-induced cerebral ischemia and cell death in rats. Journal of Applied Physiology. 80(2). 680–684. 37 indexed citations

17.

Lin, Mao‐Tsun, Ting‐Yu Kao, Chung‐Ching Chio, & Ying Jin. (1995). Dopamine depletion protects striatal neurons from heatstroke-induced ischemia and cell death in rats. American Journal of Physiology-Heart and Circulatory Physiology. 269(2). H487–H490. 46 indexed citations

18.

Chiu, Wen‐Ta, Ting‐Yu Kao, & Mao‐Tsun Lin. (1995). Interleukin-1 receptor antagonist increases survival in rat heatstroke by reducing hypothalamic serotonin release. Neuroscience Letters. 202(1-2). 33–36. 26 indexed citations

19.

Lin, M. T., et al.. (1994). Interleukin-1β production during the onset of heat stroke in rabbits. Neuroscience Letters. 174(1). 17–20. 74 indexed citations

20.

Kao, Ting‐Yu, Chung‐Ching Chio, & Mao‐Tsun Lin. (1994). Hypothalamic dopamine release and local cerebral blood flow during onset of heatstroke in rats.. Stroke. 25(12). 2483–2486. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact